Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction by Quirino Ciampi & Bruno Villari
BioMed CentralCardiovascular Ultrasound
ssOpen AcceReview
Role of echocardiography in diagnosis and risk stratification in heart 
failure with left ventricular systolic dysfunction
Quirino Ciampi* and Bruno Villari
Address: Division of Cardiology, Fatebenefratelli Hospital, Benevento, Italy
Email: Quirino Ciampi* - qciampi@iol.it; Bruno Villari - bruno.villari@tin.it
* Corresponding author    
Abstract
Heart failure (HF) is a complex clinical syndrome that can result from any structural or functional
cardiac disorder that impairs the ability of the ventricle to fill with or eject blood. Echocardiography
represents the "gold standard" in the assessment of LV systolic dysfunction and in the recognition
of systolic heart failure, since dilatation of the LV results in alteration of intracardiac geometry and
hemodynamics leading to increased morbidity and mortality.
The functional mitral regurgitation is a consequence of adverse LV remodelling that occurs with a
structurally normal valve and it is a marker of adverse prognosis.
Diastolic dysfunction plays a major role in signs and symptoms of HF and in the risk stratification,
and provides prognostic information independently in HF patients and impaired systolic function.
Ultrasound lung comets are a simple echographic sign of extravascular lung water, more frequently
associated with left ventricular diastolic and/or systolic dysfunction, which can integrate the clinical
and pathophysiological information provided by conventional echocardiography and provide a
useful information for prognostic stratification of HF patients.
Contractile reserve is defined as the difference between values of an index of left ventricular
contractility during peak stress and its baseline values and the presence of myocardial viability
predicts a favorable outcome. A non-invasive echocardiographic method for the evaluation of
force-frequency relationship has been proposed to assess the changes in contractility during stress
echo.
In conclusion, in HF patients, the evaluation of systolic, diastolic function and myocardial contractile
reserve plays a fundamental role in the risk stratification. The highest risk is present in HF patients
with a heart that is weak, big, noisy, stiff and wet.
Background
Heart failure (HF) is a complex clinical syndrome that can
result from any structural or functional cardiac disorder
that impairs the ability of the ventricle to fill with or eject
blood [1].
The syndrome of HF is a common manifestation of the
later stages of various cardiovascular diseases, including
coronary artery disease, hypertension, valvular disease,
and primary myocardial disease.
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fatigue, which may limit exercise tolerance, and fluid
retention, which may lead to pulmonary congestion and
peripheral edema. Both abnormalities can impair the
functional capacity and quality of life of affected individ-
uals, but they do not necessarily dominate the clinical pic-
ture at the same time. Some patients have exercise
intolerance but little evidence of fluid retention, whereas
others complain primarily of edema and report few symp-
toms of dyspnea or fatigue [2,3].
Approximately 50% of HF patients present with evidence
of left ventricular systolic dysfunction manifested as a low
left ventricular ejection fraction [4].
HF is considered a progressive disorder that can be repre-
sented as a clinical continuum. The American College of
Cardiology/American Heart Association (ACC/AHA)
updated 2005 guidelines for the management of chronic
HF identify 4 stages in this continuum. Stage A: risk for HF
but without structural heart disease or symptoms of HF;
Stage B: structural heart disease but without signs or
symptoms of HF; Stage C: structural heart disease with
prior or current symptoms of HF; Stage D: refractory HF
[5]. The number of patients with LV systolic dysfunction
in stage B is estimated to be 4 times greater than in stages
C and D combined [6]. These patients remain at risk for
significant morbidity and mortality and the subsequent
development of symptomatic HF. Because substantial evi-
dence indicates that pharmacological intervention may
have an effect on the risk of progression to HF and death,
identification of patients who are asymptomatic would
then appear to be a priority.
ACC/AHA guidelines [5] as well as ESC guidelines [7]
state that echocardiography is the single most useful test
in the diagnosis of heart failure since structural abnormal-
ity, systolic dysfunction, diastolic dysfunction, or a com-
bination of these abnormalities needs to be documented
in patients who present with resting or/and exertional
symptoms of heart failure to establish a definitive diagno-
sis of heart failure (Figure 1). It is important to demon-
strate an objective evidence of structural or functional
abnormalities to explain patient's symptoms of heart fail-
ure since symptoms of heart failure are not specific and
more than a third of patients with a clinical diagnosis of
heart failure may not actually have heart failure [8].
European Society of Cardiology guidelines [5] recom-
mend chest x-ray for the evaluation of patients with sus-
pected LV dysfunction because of signs or symptoms. In
particular, chest x-ray is useful to detect the presence of
cardiac enlargement and pulmonary congestion. How-
ever, echocardiography represents the "gold standard" in
the assessment of LV systolic dysfunction, it can certainly
do better than chest x-ray for cardiac enlargement, and
may also provide direct imaging of pulmonary conges-
tion. In addition, it is important to consider the disadvan-
tage of radiation exposure in situations, such as heart
failure, when serial assessment is mandatory [9,10]. Cur-
rent protection standard and practices are based on the
premise that any ionising radiation dose, no matter how
small, can result in detrimental health effects [11]. These
include long-term development of cancer and genetic
damage [12]. For the purposes of radiation protection, the
dose-response curve for radiation-induced cancer is
assumed to be linear at low doses, with no minimum
threshold [13].
Owing to high cost and the need for skilled technicians, in
the absence of some other clinical indication, such as a
prior myocardial infarction, abnormality of electrocardio-
gram, family history of cardiomyopathy, or HF symp-
toms, routine comprehensive echocardiography cannot
be recommended currently.
Left ventricular systolic dysfunction (the weak heart)
Heart failure due to systolic dysfunction is relatively easy
to diagnose by echocardiography which demonstrates a
dilated left ventricle with a reduced ejection fraction. In
systolic heart failure, however, echocardiography has
many other roles beyond the recognition of systolic heart
failure since dilatation of the LV results in alteration of int-
racardiac geometry and hemodynamics leading to
increased morbidity and mortality [14].
Left ventricular dimensions, volumes and wall thicknesses
are echocardiographic measurements widely used in clin-
ical practice and research. To obtain accurate linear meas-
urements of interventricular septal and posterior wall
thicknesses and LV internal dimension, recordings should
Algorithm of diagnosis of heart failure or left ventricular dys-functionFi u e 1
Algorithm of diagnosis of heart failure or left ventricular dys-
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[15]. It is recommended that LV internal diameters and
wall thicknesses be measured at the level of the LV minor
axis, approximately at the mitral valve leaflet tips (Figure
2). However, it should be recognized that even with 2-
dimensional echo (2D) guidance, it may not be possible
to align the M-mode cursor perpendicular to the long axis
of the ventricle which is mandatory to obtain a true minor
axis dimension measurement. Alternatively, chamber
dimension and wall thicknesses can be acquired from the
parasternal short-axis view using direct 2D measurements
or targeted M-mode echocardiography provided that the
M-mode cursor can be positioned perpendicular to the
septum and LV posterior wall [15].
In order to obtain volumetric measurements the most
important views for 2D quantization are the mid-papil-
lary short-axis view and the apical four and two-chamber
views [15]. Volumetric measurements require manual
tracing of the endocardial border. The papillary muscles
should be excluded from the cavity in the tracing. Accurate
measurements require optimal visualization of the endo-
cardial border in order to minimize the need for extrapo-
lation. The most commonly used 2-D measurement for
volume measurements is the biplane method of discs
(modified Simpson's rule) [16]. The principle underlying
this method is that the total LV volume is calculated from
the summation of a stack of elliptical discs. The height of
each disc is calculated as a fraction (usually one-twenti-
eth) of the LV long axis based on the longer of the two
lengths from the two and four-chamber views (Figure 3).
End-diastole can be defined at the onset of the QRS, but is
preferably defined as the frame following mitral valve clo-
sure or the frame in the cardiac cycle in which the cardiac
dimension is largest. End-systole is best defined as the
frame preceding mitral valve opening or the time in the
cardiac cycle in which the cardiac dimension is smallest in
a normal heart. LV size and performance are still fre-
quently visually estimated. However, qualitative assess-
ment of LV size and function may have significant inter-
observer variability and is a function of interpreter skill.
Therefore, it should regularly be compared to quantitative
measurements, especially when different views qualita-
tively suggest different degrees of LV dysfunction. Simi-
larly, it is also important to cross-check quantitative data
using the "eye-ball" method, to avoid overemphasis on
process-related measurements, which at times may
depend on structures seen in a single still-frame. While
these inaccuracies in the measurement of LV volume and
ejection fraction have been considered inevitable and of
minor clinical importance in the past, in most situations
accurate measurements are required, particularly when
following the course of a disease with serial examinations
[17].
2-D measurements for volume calculations using the biplane method of discs (modified Simpson's rule), in the apical four-chamb r (A4C) and apical two- hamber (A2C) views at e ddiastol (LV EDD) and at end-systole (LVESD)Figur  3
2-D measurements for volume calculations using the biplane 
method of discs (modified Simpson's rule), in the apical four-
chamber (A4C) and apical two-chamber (A2C) views at end 
diastole (LV EDD) and at end-systole (LVESD). The papillary 
muscles should be excluded from the cavity in the tracing.
Measurement of left ventricular end-diastolic diameter (EDD) and end-systolic diameter (ESD) fr m M- ode down), guide  b  a parastern l short axis i age (upper) to optimiz  m dial-lateral be  o i ta ionFigure 2
Measurement of left ventricular end-diastolic diameter 
(EDD) and end-systolic diameter (ESD) from M-mode 
(down), guided by a parasternal short axis image (upper) to 
optimize medial-lateral beam orientation.Page 3 of 12
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niques became available to measure LV volumes and ejec-
tion fraction. Regardless of which acquisition or analysis
method is used, 3D echocardiography does not rely on
geometric assumptions for volume/mass calculations and
is not subject to plane positioning errors [18,19]. Studies
comparing 3D echocardiographic LV volumes to other
gold-standards such as magnetic resonance imaging, have
confirmed 3D echocardiography to be accurate. Com-
pared to magnetic resonance data, LV volumes calculated
from 3D echocardiography showed significantly better
agreement (smaller bias), lower scatter and lower intra-
and inter-observer variability than 2-D echocardiography
[20]. Current limitations include the requirement of regu-
lar rhythm, relative inferior image quality of real-time 3D
echocardiography compared to 2D images, and the time
necessary for off-line data analysis.
The LV systolic function is normal if ejection fraction is
>55%, and considered severely abnormal if ejection frac-
tion is <30% (Table 1).
For the analysis of the regional function, in 2002 the
American Heart Association Writing Group on Myocar-
dial Segmentation and Registration for Cardiac Imaging
[21], in an attempt to establish segmentation standards
applicable to all types of imaging, recommended a 17-seg-
ment model. This model consists of six segments at both
basal and mid-ventricular levels and four segments at the
apex. The 17th segment, the "apical cap" is the segment
beyond the end of the LV cavity.
Left ventricular remodeling (the big heart)
Transition to pathologic remodeling is heralded by pro-
gressive ventricular dilatation, distortion of cavity shape
and disruption of the normal geometry of the mitral
annulus and subvalvular apparatus resulting in mitral
regurgitation [22].
Pathologic LV remodeling is the final common pathway
to heart failure, whether the initial stimulus is chronic
pressure or chronic volume overload, genetically deter-
mined cardiomyopathy or myocardial infarction.
Changes in LV size and geometry due to pressure overload
reflect the dominant underlying hemodynamic altera-
tions associated with blood pressure elevation. The pres-
sure-overload pattern of concentric hypertrophy is
uncommon in otherwise healthy hypertensive individuals
and is associated with high systolic blood pressure and
high peripheral resistance. In contrast, the volume-over-
load pattern is characterized by eccentric LV hypertrophy
and it is associated with normal peripheral resistance but
high cardiac index consistent with excess circulating
blood volume [23,24].
While LV remodeling in patients with chronic systemic
hypertension, chronic valvular regurgitation and primary
cardiomyopathies has been described, the transition to
heart failure is less well known because the time course is
so prolonged. By contrast, the time course from myocar-
dial infarction to heart failure is shorter and has been
clearly documented. A unique form of remodeling occurs
following myocardial infarction due to the abrupt loss of
contracting myocytes. Early expansion of the infarct zone
is associated with early LV dilatation as the increased
regional wall stress is redistributed to preserve stroke vol-
ume. The extent of early and late post-infarction remode-
ling is determined by a number of factors, including size
and location of infarction, activation of the sympathetic
nervous system, and up-regulation of the renin/angi-
otensin/aldosterone system and natriuretic peptides [25].
The traditional quantitative echocardiographic measure-
ments recommended to evaluate LV remodeling included
estimates of LV volumes either from biplane images as
advocated by the American Society of Echocardiography
[11]. LV volumes and derived ejection fraction have been
demonstrated to predict adverse cardiovascular events at
follow-up, including death, recurrent infarction, heart
failure, ventricular arrhythmias and mitral regurgitation
in numerous post-infarction and heart failure trials
[25,26].
Mitral regurgitation (the noisy heart)
Mitral regurgitation is a common finding in HF patients.
In patients with dilated and ischemic cardiomyopathy,
the mitral regurgitation is typically functional and reflects
geometric distortions of LV chamber, which displaces the
normal valve and subvalvar closing mechanisms [27].
This functional mitral regurgitation is a consequence of
adverse LV remodelling and increased sphericity of the
chamber. Functional mitral regurgitation is typically
dynamic, occurs with a structurally normal valve and it is
a marker of adverse prognosis [28,29]. Mitral regurgita-
tion further increases the propensity for severity of HF. In
fact, LV dilatation begets mitral regurgitation and mitral
Table 1: The risk factor in patients with systolic heart failure
Abnormality
Mild Moderate Severe
LV end-systolic volume (ml/m2) <30 30–60 >60
LV ejection fraction (%) 45–54 44–30 <30
Transmitral LV diastolic 
dysfunction (E/A)
Grade I Grade II-III Grade IV
Tissue Doppler diastolic 
dysfunction (E/E')
<8 8–15 >15
Ultrasound Lung Comets 5–15 16–30 >30
Mitral regurgitation (Jet/left atrial) <20 20–40 >40Page 4 of 12
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remodeling and contractile dysfunction [30].
The presence and degree of mitral regurgitation compli-
cating HF are unrelated to the severity of systolic dysfunc-
tion. Local LV remodeling (apical and posterior
displacement of papillary muscles) leads to excess valvu-
lar tenting independent of global LV remodeling. In turn,
excess tenting and loss of systolic annular contraction are
associated with larger mitral regurgitation. Tenting is char-
acterized by insufficient systolic leaflet body displacement
toward the annulus, with coaptation limited to leaflet
tips. Valvular tenting area was measured by the area
enclosed between the annular plane and mitral leaflets
from the parasternal long-axis view at early and late sys-
tole. The distance between leaflet coaptation and the
mitral annulus plane at early and end systole measured
displacement of mitral coaptation toward the LV apex
[27,30,31].
In a study with 3-D echocardiography [32], the authors
demonstrated that in ischemic cardiomyopathy–mitral
regurgitation, the LV chamber and mitral annulus were
less enlarged than in dilated cardiomyopathy despite the
presence of virtually the same grade of mitral regurgita-
tion. In ischemic cardiomyopathy–mitral regurgitation,
the pattern of mitral valve deformation from the medial to
the lateral side of the mitral valve was asymmetrical (sig-
nificant tethering of both leaflets on the medial side, but
significant tethering of only the posterior leaflet on the
lateral side), whereas it was symmetrical in dilated cardio-
myopathy – mitral regurgitation (significant tethering of
both leaflets on both sides). Hence, 3-D echocardiogra-
phy is a helpful tool for differentiating the geometry of the
mitral apparatus between these 2 different types of func-
tional mitral regurgitation. This finding suggests that in
ischemic cardiomyopathy–mitral regurgitation, mitral
regurgitation severity is mainly associated with regional
geometry of the LV chamber rather than global geometry.
Stress echocardiography in the form of exercise or phar-
macologic protocols can be useful in the assessment of
mitral regurgitation, and it can play several roles in the
assessment of the behaviour of mitral valve in HF patients
[33]. In symptomatic patients with LV dysfunction and a
clinical picture suspicious for new or worsening mitral
regurgitation, but not evident at resting echo examina-
tion, exercise echocardiography can demonstrate a wors-
ening of mitral regurgitation which helps to correlate this
scenario with the patient's symptoms [34]. LV contractil-
ity, in presence of mitral regurgitation, can impair or
improve during exercise with consequent modification of
mitral regurgitation. The presence of myocardial contrac-
tile reserve is related to decrease of mitral regurgitation
[35], whereas generally a fall in stroke volume is associ-
ated with an increase in mitral regurgitant volume is asso-
ciated with an increase in mitral regurgitant volume
during isometric exercise, which increases systemic resist-
ances and thereby afterload [36]. These observations sup-
port the concept of presence of a vicious circle between LV
function and behaviour of mitral regurgitation. Therefore,
to study these patients with exercise echocardiography
may be important for assessing the response of mitral
regurgitation to medical therapy and for the following
prognostic implications. Indeed, in patients with ischemic
mitral regurgitation and LV dysfunction, quantitative
assessment of exercise-induced changes in the degree of
mitral regurgitation provides independent prognostic
information [37].
Left ventricular diastolic dysfunction (the stiff heart)
Diastolic dysfunction refers to the presence of abnormali-
ties in filling of the ventricle [38].
LV filling consists series of hemodynamic events that are
affected by multiple intrinsic and extrinsic factors. The ini-
tial diastolic event is myocardial relaxation, an active
energy-dependent process, that causes a decrease rapidly
in the pressure of left ventricle after the end of contraction
and during early diastole. Doppler echocardiography is an
extremely sensitive tool for the detection and measure-
ment of pressure gradient (driving force) from the left
atrium to the LV during diastole [39-41].
When LV pressure falls below left atrial pressure, the
mitral valve opens and rapid early diastolic filling begins.
Approximately 80% of LV filling normally occurs during
this phase. As a result of rapid filling, LV pressure increases
and exceeds left atrial pressure, and this loss of positive
driving force results in deceleration of mitral flow veloc-
ity. A positive transmitral pressure gradient and flow are
again created by atrial contraction during late diastolic.
Mitral flow velocities are obtained by pulsed-wave Dop-
pler echocardiography with the sample volume located
between the tips of mitral leaflets during diastole. Initial
classification of diastolic filling is made from peak veloc-
ity of early rapid filling wave (E), peak velocity of late fill-
ing wave caused by atrial contraction (A), and E/A ratio.
Diastolic filling pattern is characterized further by measur-
ing deceleration time, which is the interval from the peak
of E velocity to its extrapolation to the baseline [39-41].
In the early stages of diastolic dysfunction, impaired
(delayed) relaxation of the left ventricle predominates,
and this decreases early diastolic filling. An abnormal
relaxation pattern is seen on the mitral flow velocity curve
and consists of a low E velocity, prolongation of the decel-
eration time and increased filling at atrial contraction. The
deceleration time is characteristically prolonged because itPage 5 of 12
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brated with a slower and continued fall in LV pressure
until mid to late diastole and a reduced rate of filling dur-
ing early diastole (E). At this stage, there is little if any
increase in rest left ventricular diastolic filling pressure
[42].
With disease progression, left atrial pressure increases,
thus increasing the driving pressure across the mitral
valve. There is a gradual increase in the E velocity on the
mitral flow velocity curve. As effective operative compli-
ance decreases, the deceleration time shortens, and a
pseudonormal pattern appears. In more advanced dis-
ease, the left atrial pressure is higher and ventricular com-
pliance is poor, producing a restriction to filling pattern.
On the basis of this progression of disease patterns, we
would like to propose a grading system for the severity of
diastolic dysfunction as assessed with Doppler echocardi-
ography [43]. Using a scale of I to IV, grade I identifies a
patient with an abnormal relaxation pattern and minimal
or no symptoms of heart failure at rest. Patients with grade
I diastolic dysfunction may develop dyspnea with moder-
ate to extreme exertion or may develop symptoms of heart
failure if the contribution from atrial contraction is lost, as
occurs with development of atrial fibrillation. With grade
II diastolic dysfunction, there is a pseudo-normalization
pattern on the mitral flow velocity curves and increased
filling pressures at rest, producing symptoms with mild to
moderate exertion. Patients with grade III diastolic dys-
function have a restrictive reversible filling pattern on the
mitral flow velocity curves, severe increase in filling pres-
sures and symptoms at rest or with minimal exertion.
Some patients with severe abnormalities of ventricular
compliance and end-stage heart disease maintain a severe
restrictive pattern even after aggressive diuresis. Grade IV
is characterized by a restrictive irreversible filling pattern.
Previous works showed that restrictive LV filling pattern,
in HF patients, is associated with a more severe clinical
and hemodynamic status and with increased mortality: it
is an independent prognostic marker [44-47].
Tissue Doppler imaging (TDI) is an echocardiographic
technique with the capacity to quantify systolic and
diastolic functions both globally and regionally [48,49].
TDI is useful for the detection of left ventricular systolic
and diastolic dysfunction, because it integrates detailed
information of regional function to estimate global car-
diac function. Systolic function is in fact one of the most
important determinants of diastolic function: in fact
systolic and diastolic functions are closely coupled in the
cardiac cycle and both are energy-dependent processes. Yu
et al. [50] demonstrated that, in patients with diastolic
heart failure, there is objective evidence of impaired left
ventricular systolic function as demonstrated by TDI. In
these patients, the regional function, assessed by mitral
anulus peak systolic velocity, was decreased. The mitral
anulus peak systolic velocity appears to be a more sensi-
tive index of early systolic dysfunction than ejection frac-
tion and, hence, in a proportion of these patients the
systolic function was labeled as "normal" by conventional
methods. This indicates the common coexistence of systo-
lic and diastolic dysfunction in a spectrum of different
severity in the pathophysiological process of heart failure.
The velocity of annular motion reflects shortening and
lengthening of the myocardial fibers along a longitudinal
plane. The mitral annulus early diastolic velocity (Ea) is
an index of LV relaxation that may not be influenced by
left atrial pressure. Ea is lower at the septal annulus (nor-
mal >10 cm/sec) compared to the lateral annulus (normal
>15 cm/sec). Using early diastolic velocity of mitral anu-
lus, Nagueh et al [51] identified patients with relaxation
abnormalities independent of the filling pressures and,
consequently, differentiated the pseudonormal from the
normal LV filling pattern. Furthermore, the ratio of the
transmitral E velocity of mitral flow and early diastolic
velocity of mitral anulus is related significantly with pul-
monary capillary Wedge pressure, suggesting that this
measurement can be used as an index of filling pressures.
Ultrasound lung comets (the wet heart)
The interstitial pulmonary edema is a key parameter in the
management of patients with chronic heart failure and an
early warning sign of impending acute heart failure. The
objective diagnosis is traditionally based on chest radio-
graphic findings which, when performed at the bedside,
may be difficult to interpret, and may have weak correla-
tions with extravascular lung water [52,53]. The lung is
considered poorly accessible using ultrasound since air
prevents the progression of the ultrasound beam with pro-
duction of reverberation artifacts under the lung surface
[54]. The "comet-tail image" is an echographic image
detectable at bedside with ultrasound probes positioned
over the chest [55]. This image consists of multiple comet
tails fanning out from the lung surface originating from
water-thickened interlobular septa. Functionally, they are
a sign of distress of the alveolar-capillary membrane,
often associated with reduced ejection fraction and
increased pulmonary wedge pressure and they probably
represent an ultrasonic equivalent of radiologic Kerley B
lines [56]. These features make ultrasound lung comets an
appealing simple clinically useful sign for detecting and
quantifying extravascular lung water [57] in patients with
known or suspected heart failure. Thus, their presence and
number permit quantification of the excess of extravascu-
lar lung water, providing an indirect measurement of
wedge pressure. Moreover, it is sufficiently sensitive and
accurate to detect pulmonary interstitial edema even
before it becomes apparent clinically. This turns into anPage 6 of 12
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early stage of pulmonary edema, appearing below the
threshold of alveolar edema [58]. In fact, alveolar edema
is always preceded by interstitial edema, a constant feature
of pulmonary edema, the radiologic diagnosis of which is
difficult at bedside.
Bedside chest ultrasound has numerous clinical advan-
tages. Recognition of the comet-tail image provides
immediate noninvasive information; it can be performed
at bedside also with an unsophisticated hand-held device;
it is very simple to interpret and easy to quantify; it is not
dependent on cardiac acoustic window or patient decubi-
tus; the learning curve is short; and due to the no-ionizing
nature of the examination, it is useful in following up the
patient over time and tailoring therapy. Ultrasound lung
comets are easy both to obtain and to measure (learning
curve of <10 examinations, 30 minutes) and fast to per-
form (<3 minutes), require very limited technology, even
without a second harmonic or Doppler and are not
restricted by cardiac acoustic window limitations or
patient decubitus [56,57].
In patients with acute heart failure were directly related to
NYHA functional class, BNP levels and severity of diasto-
lic dysfunction and inversely related to ejection fraction
[59]. The same group demonstrated that the 16-months
event-free survival was highest in patients without ultra-
sound lung comets and lowest in patients with severe
(>30) ultrasound lung comets at entry. At univariate anal-
ysis, were more powerful predictors than other echocardi-
ographic variables [60].
Finally, ultrasound lung comets are a simple echographic
sign of extravascular lung water, more frequently associ-
ated with left ventricular diastolic and/or systolic dysfunc-
tion. Ultrasound lung comets can usefully integrate the
clinical and pathophysiological information provided by
conventional 2D and Doppler echocardiography in
patients with known or suspected heart failure and dysp-
nea as a presenting symptom and provide a useful infor-
mation for prognostic stratification of patients with
dyspnea.
Stress echo: evaluation of myocardial viability
Despite the wealth evidence that favor use of stress
echocardiography in patients with dilated cardiomyopa-
thy [61-65], there is no clear algorithm about its use in risk
stratification and therapeutic strategy. The reasons for this
are not clear, but probably reflect the lack of standardized
protocol and measurements of left ventricular contractile
reserve. Unlike protocols for stress-echocardiography for
coronary artery disease, there is no consensus about the
protocol to be used in patients with left ventricular systo-
lic dysfunction. The majority of authors have used either
low- or high dose dobutamine echocardiography.
All studies on stress-echocardiography in HF patients
measured contractile reserve of the left ventricle. Contrac-
tile reserve is defined as the difference between values of
an index of left ventricular contractility during peak stress
and its baseline values. There is no consensus on what
index to use. Ejection fraction is the most frequently used
index of left ventricular performance. However, it may not
accurately reflect left ventricular contractility since it is
heavily dependent on loading conditions which is partic-
ularly important in patients with heart failure for the fol-
lowing reasons [66]. First of all, mitral regurgitation is
frequent in these patients, and can lead to overestimation
of left ventricular contractility due to rise in ejection frac-
tion caused by changes in loading conditions (higher
preload, lower afterload) [67]. Secondly, activation of
neuroendocrine compensatory mechanisms may increase
afterload, which in turn may subsequently decrease ejec-
tion fraction [68]. Thirdly, left ventricular preload is
dependant upon interventricular interaction which is
exaggerated in cases of pulmonary hypertension [69] a fre-
quent finding in HF patients. It is generally accepted that
increase in ejection fraction by ≥ 5% or change from base-
line ejection fraction by ≥ 20% during stress-echocardiog-
raphy identifies patients with preserved left ventricular
contractile reserve and better prognosis. Ejection fraction
should be assessed by Simpson biplane formula.
Wall motion score index assessed in a standard manner
[16] was frequently used to assess the presence of myocar-
dial viability in dilated cardiomyopathy [62,70]. The
major potential drawback for use of this index is semi-
quantitive assessment of wall motion, which is even more
subjected to inter- and intraobserver variability in heart
failure patients due to pre-existing wall motion abnormal-
ities and substantial number of patients with left bundle
branch. It has been suggested that dobutamine induced
change in wall motion score index of ≥ 0.44 identifies
patients who will do better during the follow-up.
The assessment of force-frequency relationship is a theo-
retically robust approach for evaluating left ventricular
contractility, which has been deployed clinically using
invasive, complex and technically demanding methods
[71,72]. Recently, a non-invasive echocardiographic
method has been proposed to assess the changes in con-
tractility during exercise echo [73-75]. To build the force-
frequency relationship, the force is determined at each
step as the ratio of the systolic pressure (cuff sphygmoma-
nometer)/end-systolic volume index (biplane Simpson
rule/body surface area). This novel method is based upon
the proven assumption that positive inotropic interven-
tions are mirrored by smaller end-systolic volumes andPage 7 of 12
(page number not for citation purposes)
Cardiovascular Ultrasound 2007, 5:34 http://www.cardiovascularultrasound.com/content/5/1/34higher end-systolic pressures. Abnormal responses were
identified on the basis of the lower absolute value of
force-frequency relationship slope and of the lower criti-
cal heart rate in the presence of an abnormal biphasic
response of force-frequency relationship over increasing
frequencies. The force-frequency relationship is defined
up-sloping (normal) when peak exercise systolic pressure/
end-systolic volume index is higher than baseline and
intermediate stress values. The abnormal responses are:
biphasic, with an initial up-sloping followed by a later
down-sloping trend, when peak exercise systolic pressure/
end-systolic volume index is lower than intermediate
stress values; flat or negative, when peak exercise systolic
pressure/end-systolic volume index is equal to or lower
than baseline stress values [75]. The critical heart rate is
defined as the heart rate at which systolic pressure/end-
systolic volume index reaches the maximum value during
progressive increase in heart rate; in biphasic pattern, the
critical heart rate is the heart rate beyond which systolic
pressure/end-systolic volume index has declined by 5%;
in a negative pattern the critical heart rate is the starting
heart rate [76].
In HF patients and reduced ejection fraction, the presence
of viability play an important role in the response to ther-
apy and is a key determinant in the prognosis not only in
patients with stunned myocardium after acute myocardial
infarction [77], but also in patients with dilated cardiomy-
opathy [62,78,79]. In fact the presence of myocardial via-
bility predicts a good response in ischemic HF
cardiomyopathy that underwent to myocardial revascu-
larization therapy [80], and in HF patients and LV dyssyn-
chrony (left bundle branch block and QRS >120 ms) that
underwent resynchronization therapy using biventricular
pacing and in HF patients that started or increased medi-
cal therapy [81]. The absence of myocardial viability is
related to a bad response to revascularization therapy in
ischemic cardiomyopathy, to resynchronization therapy
and to medical therapy. The unavoidable way for HF
patients with reduced systolic function without myocar-
dial viability during stress echo is the heart transplanta-
tion (Figure 4).
Evaluation of the risk in systolic heart failure
In HF patient it is very important analyzed all of the
echocardiographic parameters that we can have. We con-
sidered 2 patients with chronic HF and dilated cardiomy-
opathy after myocardial infarction. The 2 patients had a
similar ejection fraction (patient 1: 24%, patient 2: 22%)
and wall motion score index (patient 1: 2.43 patient 2:
2.54). When we assessed the diastolic function, we found
an abnormal relaxation LV filling pattern (Grade I) in
patient 1 with a normal LV filling pressure (E/E' 9.4) (Fig-
ure 5), while patient 2 had restrictive irreversible LV filling
pattern (Grade IV) and elevated LV filling pressure (E/E'
28.4), moderate mitral regurgitation and 32 ultrasound
lung comets (Figure 6). During high dose dobutamine
stress echo patient 1 showed a significant increase in wall
motion score index (from 2.43 at baseline to 1,5 at peak
stress) and in ejection fraction (from 24% at baseline to
40% at peak stress), while wall motion score index (2.54
at baseline and at peak stress) and ejection fraction (from
22% at baseline to 23% at peak stress) did not change sig-
nificantly in patient 2.
Hence this approach identifies a low risk patient (patient
1) in NYHA functional class II, with normal exercise toler-
ance (peak oxygen consumption 15,1 ml/kg/min) and
light increase in BNP levels (280 pg/ml); on the other
hand, patient 2 is a high risk, in NYHA functional class III,
with abnormal exercise tolerance (peak oxygen consump-
tion 10,2 ml/kg/min) and elevated in BNP levels (1190
pg/ml).
Both of patient underwent to cardiac resynchronization
therapy. At 1-year follow-up, patient 1 was a responder to
resynchronization therapy: in fact it showed an improve-
ment in symptoms (NYHA functional class I) with a sig-
nificant reduction in end-systolic volume (from 137 ml to
107 ml, ∆ -22%) and increase in ejection fraction (from
24% to 33%, ∆ +37%). Patient 1 was a non-responder: the
symptoms did not change (NYHA functional class III),
without a significant reduction in end-systolic volume
(from 115 ml to 102 ml, ∆ -11%) and increase in ejection
fraction (from 22% to 25%, ∆ +13%).
Conclusion
In HF patients, the evaluation of systolic, diastolic func-
tion and myocardial contractile reserve play a fundamen-
tal role in the risk stratification (Figure 7). In fact, as we
demonstrated in the example, the evaluation of systolic
Role of stress echo viability in heart failureFigure 4
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Transmitral LV filling pattern (up); mitral annulus pulsed Tissue Doppler velocity at septum (left panel) septal (down left) and lateral wall (down right) cornerFigure 6
Transmitral LV filling pattern (up); mitral annulus pulsed Tissue Doppler velocity at septum (left panel) septal (down left) and 
lateral wall (down right) corner.
Transmitral LV filling pattern (up); mitral annulus pulsed Tissue Doppler velocity at septum (left panel) septal (down left) and lateral wall (down right) cornerFigure 5
Transmitral LV filling pattern (up); mitral annulus pulsed Tissue Doppler velocity at septum (left panel) septal (down left) and 
lateral wall (down right) corner.
Cardiovascular Ultrasound 2007, 5:34 http://www.cardiovascularultrasound.com/content/5/1/34function (i.e. ejection fraction), that often comes
demanded like a single parameter of appraisal of the
severity of HF patient, it is a part in the assessment of the
risk: the highest risk is present in HF patients with heart
weak, big, noisy, stiff and wet.
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